Who invested in Marinus Pharmaceuticals?
Marinus Pharmaceuticals's investors include Canaan, Domain Associates, Sofinnova Investments and Foundation Medical Partners.
United States · Series C startup
3 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$52Mraised across 3 rounds since 2009, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by finsmes.comSEC filing: $11M sold, first sale Dec 2012
No investor was named in the report.
Reported by sec.govSEC filing: $11M sold, first sale Dec 2012
Reported by onbiovc.comSEC filing: $20M sold, first sale Apr 2009
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Marinus Pharmaceuticals's investors include Canaan, Domain Associates, Sofinnova Investments and Foundation Medical Partners.
Marinus Pharmaceuticals has raised $52M across 3 rounds since 2009.
Marinus Pharmaceuticals's most recent round was a Series C of $21M in Jan 2013.
Its most recent round, $21M in Jan 2013, is also its largest on record.
Marinus Pharmaceuticals's first round on record, in May 2009, was backed by Canaan, Domain Associates and Sofinnova Investments and 1 others.
Marinus Pharmaceuticals's latest named round is a Series C, in Jan 2013.
Marinus Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.